Free Trial

Fractyl Health (GUTS) Competitors

Fractyl Health logo
$1.79 -0.03 (-1.65%)
(As of 12/20/2024 05:40 PM ET)

GUTS vs. DCTH, ZIMV, NPCE, RCEL, CVRX, SMTI, ZYXI, LUNG, ELMD, and CATX

Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Delcath Systems (DCTH), ZimVie (ZIMV), NeuroPace (NPCE), AVITA Medical (RCEL), CVRx (CVRX), Sanara MedTech (SMTI), Zynex (ZYXI), Pulmonx (LUNG), Electromed (ELMD), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry.

Fractyl Health vs.

Delcath Systems (NASDAQ:DCTH) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

Delcath Systems currently has a consensus price target of $21.50, suggesting a potential upside of 95.28%. Fractyl Health has a consensus price target of $22.00, suggesting a potential upside of 1,129.05%. Given Fractyl Health's higher possible upside, analysts clearly believe Fractyl Health is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Fractyl Health
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Delcath Systems has a net margin of -150.70% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Delcath Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems-150.70% -338.16% -104.02%
Fractyl Health -64,849.48%N/A -57.21%

61.1% of Delcath Systems shares are held by institutional investors. 17.9% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Delcath Systems received 27 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 25.64% of users gave Delcath Systems an outperform vote.

CompanyUnderperformOutperform
Delcath SystemsOutperform Votes
30
25.64%
Underperform Votes
87
74.36%
Fractyl HealthOutperform Votes
3
100.00%
Underperform Votes
No Votes

In the previous week, Fractyl Health had 1 more articles in the media than Delcath Systems. MarketBeat recorded 1 mentions for Fractyl Health and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.76 beat Fractyl Health's score of 0.00 indicating that Delcath Systems is being referred to more favorably in the media.

Company Overall Sentiment
Delcath Systems Positive
Fractyl Health Neutral

Delcath Systems has higher revenue and earnings than Fractyl Health. Delcath Systems is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$22.64M15.55-$47.68M-$1.35-8.16
Fractyl Health$97K887.60-$77.09M-$12.19-0.15

Summary

Delcath Systems beats Fractyl Health on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GUTS vs. The Competition

MetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$86.10M$4.34B$5.13B$9.07B
Dividend YieldN/A44.57%5.08%4.23%
P/E Ratio-0.1525.3789.5817.17
Price / Sales887.6045.951,116.12116.95
Price / CashN/A43.4542.8237.86
Price / BookN/A7.094.774.78
Net Income-$77.09M$13.64M$120.15M$225.60M
7 Day Performance-12.25%-2.93%-1.92%-1.23%
1 Month Performance-13.11%0.28%11.47%3.36%
1 Year PerformanceN/A40.76%30.54%16.60%

Fractyl Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GUTS
Fractyl Health
0.8828 of 5 stars
$1.79
-1.6%
$22.00
+1,129.1%
N/A$86.10M$97,000.00-0.15102
DCTH
Delcath Systems
2.8196 of 5 stars
$12.43
+2.6%
$21.50
+73.0%
+212.8%$397.44M$22.64M-9.6776Gap Down
High Trading Volume
ZIMV
ZimVie
2.3679 of 5 stars
$13.82
+0.7%
$18.33
+32.7%
-20.6%$381.43M$457.43M-1.052,600
NPCE
NeuroPace
3.7644 of 5 stars
$11.11
+0.7%
$14.60
+31.4%
+24.4%$331.61M$76.45M-11.03170Analyst Forecast
Positive News
RCEL
AVITA Medical
1.6504 of 5 stars
$12.53
+2.6%
$16.50
+31.7%
-5.3%$328.54M$50.14M-5.48130News Coverage
Positive News
CVRX
CVRx
3.7816 of 5 stars
$13.41
+4.5%
$16.67
+24.3%
-49.2%$325.38M$47.26M-4.75200Positive News
SMTI
Sanara MedTech
1.9969 of 5 stars
$33.76
-2.6%
$44.00
+30.3%
-14.5%$295.06M$64.99M-35.0060
ZYXI
Zynex
3.4977 of 5 stars
$8.46
+3.9%
$14.00
+65.5%
-21.1%$269.45M$184.32M54.271,100Positive News
LUNG
Pulmonx
2.6794 of 5 stars
$6.14
+0.7%
$12.75
+107.7%
-49.2%$242.46M$79.30M-4.15250
ELMD
Electromed
N/A$28.35
+0.6%
N/A+158.0%$239.78M$57.06M39.14174
CATX
Perspective Therapeutics
3.3599 of 5 stars
$3.43
-1.4%
$15.14
+341.5%
N/A$231.83M$1.43M0.00116Positive News

Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners